If you’re pregnant or hoping to become pregnant, it’s natural to have questions about your medications. And if you’re taking ...

Chinese drugmakers are racing to roll out cheaper or more innovative alternatives. Read more at straitstimes.com. Read more ...

A study found jabs were linked to a 'modestly increased risk' of diabetic retinopathy-a condition caused by damage to blood ...

(HealthDay News) — For older adults with type 2 diabetes, glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with nonarteritic anterior ischemic optic neuropathy (NAION), according ...

Obesity is a worldwide problem that is increasing. It also is associated with ocular problems. A recent study found that in addition to weight loss, the newer weight loss medications may provide ...

Personal wellness company WeightWatchers (NASDAQ:WW) reported Q2 CY2025 results beating Wall Street’s revenue expectations, ...

Research suggests Ozempic may weaken muscles even when they don’t shrink, with most lean mass loss coming from organ size reduction.

Novo Nordisk's FY 2025 guidance cuts are driven by softer U.S. Wegovy/Ozempic and GLP-1 trends. Click here to find out why I ...

Researchers have found a new effect that the popular weight loss drugs can have, it can age you back! This study is yet to be ...

Market OutlineThe Global Weight Loss Drugs Market is valued at USD 2.88 Billion in 2024 and is projected to reach a value ...

Digestion issues, fatigue, and high costs haven’t stopped some from finding power and transformation through GLP-1 medications.